In this systematic review and meta-analysis of 25 randomised controlled trials involving more than 8,000 participants, we found that people allocated to GLP-1 receptor agonists reported lower binge eating symptoms, loss of control eating, eating disinhibition, and emotional eating compared with those allocated to control groups
Withholding metformin during sick days may mitigate this risk, but trial evidence to support this approach is lacking
The link between GLP-1 agonists and easing symptoms of IBD isnt fully understood yet, but medications like Ozempic and Mounjaro are considered safe for those with Crohns or UC
Targeting IL-17 and TH17 cells in chronic inflammation
Some users find that specific dietary approaches complement semaglutide particularly well
Muchos de nuestros pacientes llegan a Austin MD despus de meses de consultas mdicas sin resultados